By analyzing genetic variations that influence drug metabolism, efficacy, and potential adverse reactions, pharmacogenomics tests provide valuable insights for personalized treatment decisions. So why are we not using it more frequently and when does it make sense to order a pharmacogenomic test?
Read MoreFor improving antimicrobial stewardship globally, several things would need to be coordinated:
Databases about outbreaks and bugs becoming resistant.
Broadscale rapid diagnostics would need to be in place to detect the bugs and resistance.
Improved antimicrobial stewardship, so the antibiotics we use today will still work in 20 or 30 years.
Defined rapid diagnostics reimbursements schemes.
Defined incentives for the development of new antibiotics.
Efforts are increasingly quantified with sensors, wearables, or even biohacking — interventions to influence body biology. The new hope for advancements in longevity is seen in artificial intelligence, which is becoming increasingly powerful.
Read MoreGene therapies are applicable to a broad range of diseases; their aim is to radically treat the causes of the diseases instead of only relieving the symptoms. They may be effective on a wide range of previously untreated diseases, such as haematological, ocular, neurodegenerative diseases, and several cancers.
In Episode 24 of Faces of digital health podcast, Natalie Pankova talks about some of the dilemmas and promises of genomics.
Read More
